How Neurocrine Biosciences makes money

Period

FY2025

How does Neurocrine Biosciences make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Neurocrine Biosciences Inc. · FY2025 · year ended 2025-12-31

Revenue$2.9BGross profit$2.8B · 98%Cost of revenue$52M · 2%Operating income$619M · 22%Operating expenses$2.2B · 77%R&D$1.0B · 36%SG&A$1.2B · 40%Other opex$17M · 1%Pre-tax income$705M · 25%Other income$86M · 3%Net income$479M · 17%Income tax$227M · 8%Product$2.8B · 99%Collaboration Revenue$27M · 1%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.